CARsgen Therapeutics

www.carsgen.com

CARsgen Therapeutics is a biopharmaceutical company focused on innovative CAR T-cell therapies for treating hematological malignancies and solid tumors. With operations in China and the U.S., the company aims to become a global leader in cell therapies, offering differentiated products like THANK-u CAR®, Cyclo CAR®, and LADAR®. Their integrated cell therapy platform and innovative pipeline position them strongly in the market, with recent FDA clinical holds lifted and ongoing pivotal trials demonstrating their commitment to making cancer curable.